We are live on
!
Find out more
GC
Grace Capital Portfolio holdings
AUM
$168M
1-Year Est. Return
21.6%
This Fund
S&P 500
This Quarter
Est. Return
+17.29%
1 Year Est. Return
+21.6%
3 Year Est. Return
+126.68%
5 Year Est. Return
+161.89%
10 Year Est. Return
–
AUM
$123M
AUM Growth
+$23.6M
(+24%)
Cap. Flow
+$7.38M
Cap. Flow
% of AUM
6.02%
Top 10 Holdings %
Top 10 Hldgs %
37.44%
Holding
204
New
69
Increased
30
Reduced
57
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Safety Insurance
SAFT
|
+$7.33M |
| 2 |
Eli Lilly
LLY
|
+$2.38M |
| 3 |
O'Reilly Automotive
ORLY
|
+$1.12M |
| 4 |
MongoDB
MDB
|
+$906K |
| 5 |
Invesco Senior Loan ETF
BKLN
|
+$771K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$3.83M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.02M |
| 3 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$1.79M |
| 4 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
+$1.11M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$574K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.42% |
| 2 | Financials | 11.93% |
| 3 | Technology | 10.96% |
| 4 | Consumer Discretionary | 6.63% |
| 5 | Consumer Staples | 5.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
1
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $14.1M | 11.5% |
177,414
-64,600
| -27% | -$3.83M |
|
|
2
Safety Insurance
SAFT
$1.09B
| $6.96M | 5.67% |
+75,187
| New | +$7.33M |
|
|
PTLA
3
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $6.47M | 5.27% |
270,832
-40,300
| -13% | -$1.11M |
|
|
MYOK
4
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $4.08M | 3.33% |
56,000
-29,500
| -35% | -$1.79M |
|
5
Texas Pacific Land
TPL
$28.7B
| $2.8M | 2.28% |
32,265
-135
| -0.4% | -$9.87K |
|
|
6
Eli Lilly
LLY
$1.05T
| $2.7M | 2.2% |
+20,518
| New | +$2.38M |
|
7
Amazon
AMZN
$2.66T
| $2.46M | 2.01% |
26,660
+2,960
| +12% | +$262K |
|
8
Visa
V
$682B
| $2.18M | 1.78% |
11,591
+380
| +3% | +$68.5K |
|
9
State Street SPDR S&P 500 ETF Trust
SPY
$774B
| $2.1M | 1.71% |
6,510
+25
| +0.4% | +$7.7K |
|
10
Meta Platforms (Facebook)
META
$1.64T
| $2.07M | 1.69% |
10,100
-700
| -6% | -$136K |
|
11
Berkshire Hathaway Class A
BRK.A
$1.06T
| $2.04M | 1.66% |
6
| – | – |
|
|
DAY
12
DELISTED
Dayforce
DAY
| $2.01M | 1.64% |
29,600
+1,000
| +3% | +$55.2K |
|
|
13
MongoDB
MDB
$25.1B
| $1.96M | 1.6% |
14,900
+6,900
| +86% | +$906K |
|
|
14
Alphabet (Google) Class A
GOOGL
$4.23T
| $1.87M | 1.53% |
28,000
+7,000
| +33% | +$452K |
|
15
Alibaba
BABA
$276B
| $1.7M | 1.38% |
8,000
| – | – |
|
16
iShares Select Dividend ETF
DVY
$23.8B
| $1.57M | 1.28% |
14,846
| – | – |
|
|
17
iShares Core S&P 500 ETF
IVV
$881B
| $1.53M | 1.25% |
4,740
-6,530
| -58% | -$2.02M |
|
18
Gilead Sciences
GILD
$167B
| $1.28M | 1.04% |
19,700
-1,300
| -6% | -$84.7K |
|
19
Altria Group
MO
$124B
| $1.26M | 1.02% |
25,175
-2,200
| -8% | -$104K |
|
20
CVS Health
CVS
$137B
| $1.25M | 1.02% |
16,772
-1,350
| -7% | -$94.8K |
|
21
Apple
AAPL
$4.9T
| $1.24M | 1.01% |
16,828
-1,640
| -9% | -$106K |
|
22
BridgeBio Pharma
BBIO
$15.9B
| $1.21M | 0.99% |
34,500
+11,000
| +47% | +$305K |
|
23
Universal Display
OLED
$3.75B
| $1.18M | 0.96% |
5,700
| – | – |
|
|
24
O'Reilly Automotive
ORLY
$71.3B
| $1.14M | 0.93% |
+39,000
| New | +$1.12M |
|
25
iShares US Consumer Staples ETF
IYK
$1.39B
| $1.1M | 0.9% |
24,900
-1,800
| -7% | -$77K |
|
Similar funds
REMS
TI
NM
KM
MC
FAC
MSO
ACM
Grace Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Grace Capital held 204 positions worth $123M, up 24% from $99M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Grace Capital deployed $7.38M of net new capital in Q4 2019, opening 69 new positions and adding to 30 existing holdings. Its largest new stake was Safety Insurance: 75,187 shares worth $6.96M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 25% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Global Blood Therapeutics, Inc., an estimated $3.83M trimmed.
- Grace Capital's largest Q4 2019 buy was Safety Insurance: 75,187 shares worth $6.96M.
- Grace Capital added most to MongoDB in Q4 2019, an estimated $906K increase.
- Grace Capital's biggest Q4 2019 reduction was Global Blood Therapeutics, Inc., cutting an estimated $3.83M.
- Grace Capital fully exited Monster Beverage in Q4 2019, selling an estimated $511K.
- Grace Capital's ten largest holdings make up 37% of its $123M portfolio in Q4 2019.
- Grace Capital opened 69 new positions and closed 11 in Q4 2019.
- Grace Capital's portfolio value rose 24% quarter-over-quarter to $123M.
Based on Grace Capital's 13F filing for Q4 2019, filed 13 Feb 2020.